Cytori (CYTX) First Patient Treated US Cell Therapy Heart Failure Trial Proactive Investors USA & Canada CYTX initiated an FDA approved ATHENA clinical trial to investigate CYTX's cell therapy in patients who suffer from a severe form of refractory (untreatable) heart failure due to chronic myocardial ischemia. This first patient was treated by co ... |
